Inhibitors of cholesterol ester transfer protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9708277
APP PUB NO 20160115138A1
SERIAL NO

14981088

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to novel oxazolidinones their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cholesterol ester transfer protein inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONCERT PHARMACEUTICALS INC99 HAYDEN AVE SUITE 500 LEXINGTON MA 02421

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Tung, Roger D Lexington, US 113 1699

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 18, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 18, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00